Roche PC - Search Results

1

HER-2/neu expression: a major prognostic factor in endometrial cancer.

Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. Hetzel DJ, et al. Among authors: roche pc. Gynecol Oncol. 1992 Nov;47(2):179-85. doi: 10.1016/0090-8258(92)90103-p. Gynecol Oncol. 1992. PMID: 1361478

2

Molecular and histopathologic predictors of distant failure in endometrial cancer.

Mariani A, Sebo TJ, Webb MJ, Riehle D, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Mariani A, et al. Among authors: roche pc. Cancer Detect Prev. 2003;27(6):434-41. doi: 10.1016/j.cdp.2003.09.005. Cancer Detect Prev. 2003. PMID: 14642551

3

Endometrial cancer: can nodal status be predicted with curettage?

Mariani A, Sebo TJ, Katzmann JA, Roche PC, Keeney GL, Lesnick TG, Podratz KC. Mariani A, et al. Among authors: roche pc. Gynecol Oncol. 2005 Mar;96(3):594-600. doi: 10.1016/j.ygyno.2004.11.030. Gynecol Oncol. 2005. PMID: 15721399

4

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.

Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Hartmann LC, et al. Among authors: roche pc. Gynecol Oncol. 1992 Nov;47(2):191-5. doi: 10.1016/0090-8258(92)90105-r. Gynecol Oncol. 1992. PMID: 1361479

5

c-erbB-2 and p53 expression in fallopian tube carcinoma.

Lacy MQ, Hartmann LC, Keeney GL, Cha SC, Wieand HS, Podratz KC, Roche PC. Lacy MQ, et al. Among authors: roche pc. Cancer. 1995 Jun 15;75(12):2891-6. doi: 10.1002/1097-0142(19950615)75:12<2891::aid-cncr2820751216>3.0.co;2-b. Cancer. 1995. PMID: 7773939

6

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

Hartmann LC, Podratz KC, Keeney GL, Kamel NA, Edmonson JH, Grill JP, Su JQ, Katzmann JA, Roche PC. Hartmann LC, et al. Among authors: roche pc. J Clin Oncol. 1994 Jan;12(1):64-9. doi: 10.1200/JCO.1994.12.1.64. J Clin Oncol. 1994. PMID: 8270986

7

Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.

Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Hamel NW, et al. Among authors: roche pc. Gynecol Oncol. 1996 Aug;62(2):192-8. doi: 10.1006/gyno.1996.0214. Gynecol Oncol. 1996. PMID: 8751548

8

Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Srivatsa PJ, et al. Among authors: roche pc. Gynecol Oncol. 1996 Mar;60(3):363-72. doi: 10.1006/gyno.1996.0056. Gynecol Oncol. 1996. PMID: 8774640

9

Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Srivatsa PJ, et al. Among authors: roche pc. Gynecol Oncol. 1997 Aug;66(2):238-45. doi: 10.1006/gyno.1997.4744. Gynecol Oncol. 1997. PMID: 9264569

10

Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.

Silverman MB, Roche PC, Kho RM, Keeney GL, Li H, Podratz KC. Silverman MB, et al. Among authors: roche pc. Gynecol Oncol. 2000 Apr;77(1):1-7. doi: 10.1006/gyno.2000.5751. Gynecol Oncol. 2000. PMID: 10739683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters